← Back

China Renaissance Holdings

3.40-56.7%1Y · HKD

China Renaissance Holdings Limited provides investment banking and investment management services in Mainland China, Hong Kong, and the United States. It operates through the Investment Banking, Investment Management, CR Securities, and Others segments. Its offerings include financial and merger and acquisition advisory, equity underwriting, sales, trading, brokerage, and research, as well as fund and asset management for individual and institutional clients and wealth management for high-net-worth individuals. Founded in 2005 and based in Beijing, China, the company is a subsidiary of CR Partners Limited.

Price · split & dividend adjusted
News & notes moving 1911.HK
ChinaUnited States
1911.HK

Tencent Music Fair Value Cut to US$13.17 as Analysts Trim Growth Views

Tencent Music Entertainment Group's fair value estimate was lowered to US$13.17 per share from US$14.97 as analysts revised their growth assumptions for the company. Mizuho kept an Outperform rating on the stock but cut its price target to US$15 from US$18, while China Renaissance downgraded the shares to Hold from Buy with a US$9.30 price target. The revised model now projects revenue growth of 7.42%, down from 9.32%, and a net profit margin of 26.31%, down from 27.53%. The future price-to-earnings multiple rose to 21.65x from 17.48x on projected earnings, and the discount rate used in the model increased to 10.32% from 9.77%. Mizuho cited more challenging trends in the core music subscription and non-subscriber music segments in the latest quarter as near-term headwinds.
Tencent Music… ▼China Renaissa… Mizuho Financi…
1698.HK · Capital · Negative Analysts cut Tencent Music's fair value and price targets, with China Renaissance downgrading to Hold, on lowered revenue growth and margin assumptions.
1911.HK · Capital · Neutral China Renaissance is cited only as the broker issuing the downgrade of Tencent Music, not as a subject of the news.
8411.JP · Capital · Neutral Mizuho is mentioned only as the analyst firm trimming its Tencent Music price target, not as a subject of the news.
Read original ↗
Simply Wall St·15dRead more →
Brain-Computer Interface▲

China's First Ultrasound Brain-Computer Interface Company Gestalt Tech Completes 420 Million Yuan Angel+ Round

China's first ultrasound brain-computer interface company Gestalt Tech has completed a 420 million yuan angel+ round of financing. This round was led by Huaying Capital, with follow-on investments from C Capital, Sequoia China, Lens Technology, China Electronics Health Fund, Sinovation Ventures, Lingang Sci-Tech Innovation Investment, Fudan Furong Capital, and Guotai Venture Capital, among other leading domestic and international investment institutions. Existing shareholders including Daotong Investment, Yunshi Capital, Qingsong Capital, and Gobi Partners continued to oversubscribe. China Renaissance acted as the exclusive financial advisor. At the same time, Gestalt Tech's Shanghai headquarters in the Brain Intelligence Park in Minhang District was officially inaugurated. As of 14:18 on July 3, 2026, the Shanghai Stock Exchange STAR Biomedical Index rose strongly by 2.69 percent. Among constituent stocks, MGI Tech rose 14.97 percent, Dizal Pharmaceutical rose 10.77 percent, and Olym Biotech rose 8.82 percent, with stocks like Youcare Pharmaceutical and Yundong Biotech also rising. The STAR Medical ETF Huaxia rose 2.17 percent, heading for a fifth consecutive gain, with the latest price at 1.08 yuan. CICC believes that innovative fields represented by AI plus healthcare and brain-computer interfaces are experiencing rapid development, with systems from supporting policies to capital support gradually improving, and such directions may present structural investment opportunities.
Lens Technolog… ▲China Renaissa… ▲MGI Tech Co. L… ▲Dizal (Jiangsu… ▲Chengdu Olymva… ▲
Brain-Computer Interface ▲
About megatrends
Brain-Computer Interface › Non-invasive BCI & Neurotech ▲Capital
格式塔科技 · Capital · Positive Completed a 420 million yuan angel+ round of financing, a significant capital event for the company.
300433.CS · Capital · Positive Participated as a follow-on investor in Gestalt Tech's financing round.
C Capital (C资本) · Capital · Positive Participated as a follow-on investor in Gestalt Tech's financing round.
CEC Health Industry Fund · Capital · Positive Participated as a follow-on investor in Gestalt Tech's financing round.
1911.HK · Capital · Positive China Renaissance acted as exclusive financial advisor for Gestalt Tech's financing round, generating advisory fee income.
688114.CG · Demand · Positive MGI Tech rose 14.97% as part of a broad rally in STAR Biomedical Index, driven by positive sentiment on AI+healthcare and brain-computer interfaces.
Read original ↗
Jiemian·95dRead more →
© 2026 MarketIVAsset